Alyeska Investment Group, L.P. - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 151 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$3,567,000
+39.7%
209,691
+41.1%
0.05%
+138.1%
Q1 2018$2,554,000
+19.4%
148,661
+16.7%
0.02%
-75.0%
Q4 2013$2,139,000
+28.1%
127,401
-0.1%
0.08%
+23.5%
Q3 2013$1,670,000127,5000.07%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Eventide Asset Management 1,085,200$44,873,0002.75%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 328,329$13,576,0000.94%
HAYS ADVISORY LLC 135,722$5,612,0000.87%
AWM Investment Company, Inc. 90,000$3,721,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 448,000$18,525,0000.73%
SPHERA FUNDS MANAGEMENT LTD. 60,000$2,481,0000.64%
RTW INVESTMENTS, LP 44,701$1,848,0000.63%
Telemetry Investments, L.L.C. 26,000$1,075,0000.58%
Spark Investment Management LLC 148,100$6,123,0000.57%
Perceptive Advisors 169,439$7,006,0000.49%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders